Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion  by Santarlasci, Veronica et al.
Immunity
ArticleRarity of Human T Helper 17 Cells
Is due to Retinoic Acid Orphan Receptor-Dependent
Mechanisms that Limit Their Expansion
Veronica Santarlasci,1,7 Laura Maggi,1,7 Manuela Capone,1 Valentina Querci,1 Luca Beltrame,3 Duccio Cavalieri,2
Elena D’Aiuto,4 Rolando Cimaz,6 Angela Nebbioso,5 Francesco Liotta,1 Raffaele De Palma,4 Enrico Maggi,1
Lorenzo Cosmi,1 Sergio Romagnani,1 and Francesco Annunziato1,*
1Department of Internal Medicine and DENOTHE Center
2Department of Pharmacology ‘‘M. Aiazzi Mancini’’
University of Florence, 50134 Firenze, Italy
3Department of Oncology, Mario Negri Institute, 20156 Milano, Italy
4Department of Clinical & Experimental Medicine
5Department of General Pathology
Second University of Naples, 80131 Napoli, Italy
6Department of Pediatrics, Rheumatology Unit, Anna Meyer Children’s Hospital and University of Florence, 50134 Firenze, Italy
7These authors contributed equally to this work
*Correspondence: f.annunziato@dmi.unifi.it
DOI 10.1016/j.immuni.2011.12.013SUMMARY
The reasonwhyCD4+ T helper 17 (Th17) cells, despite
their well-known pathogenic role in chronic inflam-
matory disorders, are very rare in the inflammatory
sites remains unclear. We demonstrate that human
Th17 cells exhibit low ability to proliferate and to
produce the T cell growth factor interleukin-2 (IL-2),
in response to combined CD3 and CD28 stimulation.
This was due to the upregulated expression of IL-4-
induced gene 1 (IL4I1) mRNA, a secreted L-phenylal-
anine oxidase, which associated with a decrease
in CD3z chain expression and consequent abnor-
malities in the molecular pathway that allows IL-2
production and cell proliferation. High IL4I1 mRNA
expression was detectable in Th17 cell precursors
and was strictly dependent on Th17 cell master
gene, the retinoid acid related orphan receptor
(RORC). Th17 cells also exhibited RORC-dependent
CD28 hyperexpression and the ability to produce
IL-17A after CD28 stimulationwithout CD3 triggering.
Our findings suggest that the rarity of human Th17
cells in inflamed tissues results from RORC-depen-
dent mechanisms limiting their expansion.
INTRODUCTION
In the past years, a subset of murine CD4+ T helper (Th) cells
showing the ability to produce IL-17A and to express the tran-
scription factor retinoic acid-related orphan receptor (ROR)gt
has been characterized and named Th17 cells (Oppmann
et al., 2000; Cua et al., 2003; Ivanov et al., 2006). Analysis of
gene-targeted models has suggested that Th17 cells are patho-
genic in several murine models of chronic inflammatory disor-ders, such as experimental autoimmune encephalomyelitis
(Cua et al., 2003), collagen-induced arthritis (Murphy et al.,
2003), and bowel inflammatory disorders (Dubin and Kolls,
2008).
Human Th17 cells have also been described and found to be,
at least partially, different from murine Th17 cells (Acosta-Rodri-
guez et al., 2007; Annunziato et al., 2007). In particular, human
Th17 cells express distinctive molecules such as IL-23R and
RORC but they share with Th1 cells the expression of IL-
12Rb2 and TBX21 (Annunziato et al., 2007). Moreover, a subset
of human IL-17A-producing CD4+ T cells were found to produce
also IFN-g (which were named Th17-Th1), and both Th17 and
Th17-Th1 cells exhibited plasticity toward the Th1 cell profile
when cultured in presence of IL-12 (Annunziato et al., 2007).
Similar findings were then observed also in some murine models
(Lee et al., 2009; Kurschus et al., 2010; Hirota et al., 2011), thus
suggesting that both human and murine Th17 cells probably
represent a transient phenotype (Annunziato and Romagnani,
2010; Murphy and Stockinger, 2010). Recently, we and others
showed that virtually all humanmemory Th17 cells are contained
within the CD161+ fraction of both circulating and tissue-
infiltrating CD4+ T cells (Cosmi et al., 2008; Kleinschek et al.,
2009) and originate from CD161+ precursors present in umbilical
cord blood (UCB) and newborn thymus (Cosmi et al., 2008;
Maggi et al., 2010). The murine equivalent of CD161 (the NK1.1
molecule) has not been described in mouse Th17 cells.
In humans, Th17 cells have also been implicated in the patho-
genesis of chronic inflammatory disorders such as autoimmune
diseases (Crohn’s disease [CD], multiple sclerosis, psoriasis,
rheumatoid arthritis) and allergic disorders (bronchial asthma,
atopic dermatitis, and contact dermatitis) (Hu et al., 2011).
However, the assessment of IL-17A-producing CD4+ T cells in
both inflamed tissues and biological fluids consistently revealed
a low frequency of these cells in comparison with the high
numbers of Th1 cells. The same observation was also done in
our previous studies performed in the intestine of patients
with CD and the synovial fluids (SF) of patients with juvenileImmunity 36, 201–214, February 24, 2012 ª2012 Elsevier Inc. 201
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Self-Regulation of Th17 Cell Expansionidiopathic arthritis (JIA) (Annunziato et al., 2007; Cosmi et al.,
2011). The reason of the unexpected rarity of Th17 cells in the
tissues and biological fluids of patients with autoimmune and
chronic inflammatory disorders, despite their suggested patho-
genic role, has remained unclear. One possible explanation
may be that Th17 cells show a transient phenotype, resulting
from their tendency to shift into Th1 cells in the context of inflam-
matory microenvironments (Annunziato and Romagnani, 2010;
Murphy and Stockinger, 2010). However, such a hypothesis
could only partially account for this phenomenon, because it
is very rare that Th17 cells can be detected even in the initial
phases of inflammation.
In the present study, we demonstrated that Th17, unlike Th1,
cells do not proliferate in response to stimulation with anti-CD3
plus anti-CD28 (anti-CD3-CD28), mainly because of their
inability to produce IL-2 and a reduced IL-2 responsiveness.
Whereas the reduced IL-2 responsiveness was explained by
the lack of PI3K-AKT-mTORC1 axis activation, the defective
IL-2 production by Th17 cells appeared to be related to their
reduced c-Fos, c-Jun, and nuclear factor of activated T cells
(NF-AT) activity. The reduced activity of these transcription
factors associated with high expression of the IL-4-induced
gene 1 (IL4I1) mRNA, which encodes for a L-phenylalanine
oxidase that has been shown to downregulate CD3z expression
in T cells (Boulland et al., 2007). IL4I1 mRNA expression was
strictly RORC dependent and was already detectable in Th17
cell precursors from UBC and newborn thymus. The production
of IL-17A was ensured by the RORC-dependent hyperexpres-
sion of CD28, which, upon stimulation, was able to induce
NF-kB phosphorylation even in absence of CD3 triggering via a
PI3K-independent pathway. These results were also confirmed
on Th17 cells ex vivo derived from inflamed sites. These findings
demonstrate that the rarity of human Th17 cells in inflamed
tissues mainly results from RORC-dependent self-regulation of
their expansion, which is probably essential to minimize their
dangerous proinflammatory activity.
RESULTS
Human Th17 Cells Neither Proliferate nor Produce IL-2
in Response to Anti-CD3-CD28 Stimulation
The ability of Th17 and Th1 cell clones to proliferate when
stimulated with anti-CD3-CD28 or PMA plus ionomycin (PMA-
Iono) was assessed with CD4+CD161+CCR6+ and CD4+CD161
CCR6 T cell populations from PB of human healthy subjects.
In vitro stimulation with anti-CD3-CD28 induced strong prolifer-
ation of Th1 cell clones, whereas it was quite ineffective on the
proliferation of Th17 cell clones (Figure 1A). Th17 cell clones
proliferated in response to PMA-Iono, although at lower extent
than Th1 cell clones (Figure 1A). IL-2 expression was then
measured in the supernatants of the above-mentioned cell
cultures. Th1 cell clones produced IL-2 upon either anti-CD3-
CD28 or PMA-Iono stimulation. In contrast, Th17 cell clones
did not produce IL-2 upon anti-CD3-CD28, but did upon PMA-
Iono stimulation, at lower extent than Th1 cell clones (Figure 1B).
Similar results were obtained by evaluating IL2 mRNA expres-
sion in Th17 and Th1 cell clones (Figure 1C).
However, the addition of IL-2 in culture only partially restored
the proliferation of Th17 cell clones (Figure 1D), indicating that202 Immunity 36, 201–214, February 24, 2012 ª2012 Elsevier Inc.the lack of Th17 cell proliferation in response to anti-CD3-
CD28 stimulation was not only due to their reduced ability to
produce this cytokine. Furthermore, the addition in culture of
IL-7, IL-15, and IL-21 increased the proliferative response of
anti-CD3-CD28-stimulated Th17 cell clones, but none of these
cytokines was able to induce a proliferation of Th17 cells compa-
rable to that of Th1 cells (data not shown). The reduced Th17 cell
proliferation in response to anti-CD3-CD28 plus IL-2was not due
to a lower mRNA expression of IL2RA, IL2RB, or IL2RG in Th17
cell clones, either (Figure S1 available online). At this point, we
investigated whether the reduced IL-2 response of Th17 cells
was due to impaired signal transduction via IL-2 receptor
(IL-2R). To this aim, we stimulated Th17 and Th1 cell clones
with IL-2 and then assessed by flow cytometry S6 ribosomal
protein (S6ribo) phosphorylation as indicator of PI3K-AKT-
mTORC1 axis activation and phosphorylation of STAT5.
IL-2 stimulation induced STAT5 phosphorylation in both Th1
and Th17 cell clones, whereas S6ribo phosphorylation was
found to be substantially higher in Th1 than in Th17 cell clones
(Figure 1E).
Also, ex-vivo-derived PB Th17 cells, unlike Th1 cells, were
unable to proliferate after anti-CD3-CD28 stimulation and the
addition in culture of IL-2 restored their proliferation (Figure 1F)
only partially.
Thus, Th17 cells do not produce IL-2 and do not proliferate in
response to the triggering of both CD3 and CD28. The stimula-
tion of Th17 cells with PMA-Iono (which bypasses cell surface
receptors), as well as the addition of exogenous IL-2 or other
T cell growth factors to anti-CD3-CD28-stimulated cells, only
partially restore Th17 cell proliferation.
Human Th17 Cells Exhibit Lower JUN, FOS, and NFATC1
mRNA Expression than Do Th1 Cells
mRNA expression of NFKB1, RELA (gene of NF-kBp65), FOS,
JUN, NFATC2, and NFATC1 was then analyzed in both Th1
and Th17 cell clones before and after their anti-CD3-CD28
stimulation. NFKB1, RELA, JUN, FOS, NFATC2, and NFATC1
mRNA expression was comparable in unstimulated Th1 and
Th17 cell clones, whereas JUN, FOS, and NFATC1 mRNA
expression appeared to be substantially lower in Th17 than
Th1 cell clones after stimulation (Figure 2A). In addition, stimula-
tion with anti-CD3-CD28 substantially upregulatedNFKB1, JUN,
FOS, andNFATC1mRNA expression in Th1 cell clones, whereas
only NFKB1 and NFATC1 mRNA expression was found
increased in Th17 cell clones (Figure 2A).
It is well known that in order to activate the IL2 promoter, the
above-mentioned transcription factors need to be either phos-
phorylated by active kinases (NF-kBp65, c-Jun, and c-Fos) or
dephosphorylated by phosphatases (NF-AT). As shown in
Figure 2B, anti-CD3-CD28 stimulation induced comparable
NF-kBp65 phosphorylation in both Th1 and Th17 cell clones
in a time-dependent manner. By contrast, anti-CD3-CD28
stimulation induced a significant phosphorylation of both c-Fos
and c-Jun in Th1 but not in Th17 cell clones (Figure 2B). More-
over, 40 min after their anti-CD3-CD28 stimulation, Th17 cells
had substantially lower NF-ATc2 nuclear localization than did
Th1 cells (Figure 2C). Finally, the Lenti NF-AT Reporter assay
clearly revealed reduced NF-AT binding to the transcriptional
regulatory element (TRE) of IL2 promoter in Th17 cell clones
Figure 1. Impaired Th17 Cell Proliferation after Anti-CD3-CD28 Stimulation Is due to Their Inability to Produce and to Respond to IL-2
(A and B) Th1 (n = 10) and Th17 (n = 10) cell clones were stimulated with anti-CD3-CD28 or PMA-iono and then assessed at day 5 for (A) proliferation by 3H-TdR
uptake and (B) IL-2 production as evaluated in supernatants.
(C) Th1 (n = 10) and Th17 (n = 10) cell clones were stimulated with anti-CD3-CD28 (6 hr) or PMA-iono (3 hr) and then assessed for IL2mRNA expression by real-
time quantitative RT-PCR. Results were normalized to GAPDH mRNA.
(D) Th1 (n = 10) and Th17 (n = 10) cell clones were stimulated with anti-CD3-CD28, in the absence or presence of IL-2, and then assessed at day 5 for proliferation
by 3H-TdR uptake.
(E) STAT5 and S6ribo phosphorylation in Th1 (n = 7) and Th17 (n = 7) cell clones induced by IL-2 stimulation was evaluated by flow cytometry. Results are
expressed as fold change of mean fluorescence intensity (MFI) in stimulated versus unstimulated (time 0) cultures. See also Figure S1.
(F) Gating strategy for FACS sorting of freshly derived PB CD4+CD161IL-17IFN-g+ (Th1) and CD4+CD161+IL-17+IFN-g (Th17) cells. One representative plot is
shown for each cell population. Freshly derived PB Th1 (n = 3) and Th17 (n = 3) cells were stimulated with anti-CD3-CD28 in the absence or presence of IL-2 and
then assessed at day 5 for proliferation by 3H-TdR uptake.
Results are expressed as mean values (±SE) of the indicated number of experiments.
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Figure 2. Reduced c-Jun, c-Fos, and NF-AT Activities in Th17 Cells
(A) NFKB1, RELA, JUN, FOS, NFATC2, and NFATC1mRNA expression in Th1 (n = 10) and Th17 (n = 10) cell clones, under the indicated culture conditions (6 hr
stimulation), was evaluated by real-time quantitative RT-PCR. Results were normalized to GAPDH mRNA.
(B) Phosphorylation of NF-kBp65, c-Jun, and c-Fos in Th1 (n = 4) and Th17 (n = 4) cell clones induced by anti-CD3-CD28 stimulation was evaluated by flow
cytometry. Results are expressed as fold change of MFI in stimulated versus unstimulated (time 0) cultures.
(C) NF-ATc2 nuclear translocation in Th1 (n = 3) and Th17 (n = 3) cell clones induced by anti-CD3-CD28 was evaluated by confocal microscopy. One repre-
sentative experiment, 40 min after anti-CD3-CD28 stimulation, is also shown. NF-ATc2 (green), To-pro3 (red), CD3 and CD28 (blue).
Immunity
Self-Regulation of Th17 Cell Expansion
204 Immunity 36, 201–214, February 24, 2012 ª2012 Elsevier Inc.
Figure 3. Reduced CD3 Expression and Activity in Th17 Cells
(A) CD3ε and CD3z expression by resting Th1 (n = 5) and Th17 (n = 5) cell clones was evaluated by flow cytometry. Results are expressed as difference between
CD3ε or CD3zMFI and their appropriate isotype control MFI. One representative plot is also shown for both CD3ε and CD3z. Dotted lines represent the staining of
isotype controls.
(B) Phosphorylation of CD3z, ZAP70, and SLP76 in Th1 (n = 4) and Th17 (n = 4) cell clones induced by anti-CD3-CD28 stimulation was evaluated by flow cy-
tometry. Results are expressed as fold change of MFI in stimulated versus unstimulated (time 0) cultures.
Results are expressed as mean values (±SE) of the indicated number of experiments.
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CD3-CD28 stimulation (Figure 2D).
Taken together, these results indicate that the intracellular
pathway responsible for IL2 promoter activation is altered in
Th17 cells.
Impaired CD3 Signaling in Th17 Cells
These findings demonstrated that several molecules involved in
IL-2 production downstream of the anti-CD3-CD28 stimulation
are downregulated in Th17 cells, and therefore the possible
level(s) of impairment was investigated. Th17 cells showed(D) Th1 (n = 8) and Th17 (n = 10) cell clones were transduced with Cignal Lenti NF
cells, was then evaluated and normalized on viable cell numbers as assessed by fl
AT activity) of stimulated versus unstimulated cultures.
Results are expressed as mean values (±SE) of the indicated number of experima substantial reduced CD3ε and CD3z chain expression when
compared to Th1 cells (Figure 3A). Along with the reduced
CD3z protein expression, stimulation of Th17 cells with anti-
CD3-CD28 resulted in a substantial reduced phosphorylation
of the CD3z chain, ZAP-70, and SLP-76, the immediate targets
of CD3z chain kinase activity (Figure 3B). In contrast, Th1 cell
clones exhibited a clear time-dependent phosphorylation of
CD3z, ZAP-70, and SLP-76 (Figure 3B).
These results indicate that the key membrane molecules
devoted to the transduction of TCR signaling exhibit both
reduced expression and activity in Th17 cells.-AT reporter. Luciferase activity, in unstimulated or anti-CD3-CD28-stimulated
ow cytometry. Results are expressed as fold change of luciferase activity (NF-
ents.
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Their Precursors
Gene expression profile of Th1 versus Th17 cell clones by a
microarray analysis showed that IL4I1 mRNA was substantially
upregulated in Th17 compared to Th1 cells (Figure S2A). IL4I1
encodes a secreted L-amino-acid oxidase that inhibits human
T lymphocyte proliferation in vitro by inducing a temporary
decrease in CD3z chain expression resulting from the enzy-
matic production of H2O2 (Boulland et al., 2007). We found
that IL4I1 mRNA expression was virtually undetectable on
either resting or activated Th1 cell clones, but it was highly
expressed on resting Th17 cell clones and further increased
by anti-CD3-CD28 stimulation (Figure 4A). IL4I1 mRNA expres-
sion was also higher in ex-vivo-derived PB Th17 than Th1 cells
(Figure 4B). Of note, IL4I1 mRNA was already expressed in
Th17 cell naive precursor, both in UCB (Figure 4C) and in
thymus of newborns (Figure 4D). More importantly, IL4I1 as
well as RORC, RORA, IL17A, and IL17F mRNAs were sub-
stantially increased in UCB-derived CD4+CD161+ cells when
cultured in the presence of IL-1b and IL-23 (Figures 4E and
S2B). Finally, IL4I1 silencing in Th17 cell clones, by using
IL4I1-specific siRNA, induced a 50% reduction of IL4I1
mRNA expression and substantially increased cell proliferation,
IL2 mRNA expression, and IL-2 production by Th17 cells
(Figures 4F and S2C).
Taken together, these results demonstrate that IL4I1 mRNA
is highly expressed in Th17 cells and that its activity is respon-
sible, at least in part, for the impairment of cell proliferation
and of IL-2 production by Th17 cells.
Upregulation of IL4I1 mRNA in Th17 Cells Is Strictly
RORC Dependent
We then askedwhether the increased IL4I1mRNAexpression, as
well as the reduced ability of human Th17 cells to produce IL-2
and to proliferate in response to anti-CD3-CD28 stimulation,
were RORC dependent. Th1 cell clones were transduced with
RORC2 or control lentivirus and then assessed for RORC,
IL17A, IL17F, IL21, IL4I1, and IL2 mRNA expression, as well as
for their ability to proliferate in response to anti-CD3-CD28 stim-
ulation. As expected, all Th1 cell clones transduced with RORC2
showed higher expression of RORC, IL17A, and IL17F mRNA
compared to cells transducedwith empty vector. The expression
of IL21 mRNA was comparable (Figures 5A and S3). Moreover,
RORC2-transduced cells had higher IL4I1 mRNA expression in
both unstimulated and anti-CD3-CD28-stimulated cells in
comparison with their empty vector-transduced counterparts
(data not shown and Figure 5A). Finally, upon anti-CD3-CD28
stimulation, RORC2-transduced Th1 cell clones showed
substantially lower IL2mRNA expression (Figure 5A) and inability
to proliferate (Figure 5B) when compared to the empty vector-
transduced cells. On the other hand, gene targeting of RORC2
expression in Th17 cell clones, via RORC2-specific small
interfering (si)RNA, resulted in a marked decrease of both
RORC and IL4I1mRNAexpression (Figure 5C) and in a significant
increase in the proliferative response (Figure 5D). Finally,
real-time quantitative RT-PCR, performed on DNA from Th17
cell clones precipitated with a RORC Ab and performed with
IL4I1-specific promoter primers, indicated the direct interaction
between RORC and IL4I1 (Figure 5E).206 Immunity 36, 201–214, February 24, 2012 ª2012 Elsevier Inc.These results indicate that IL4I1 mRNA expression is regu-
lated by the Th17 cell master gene RORC, inasmuch as its
product directly binds to the IL4I1 promoter.
CD28Stimulation Triggers Th17Cells to Produce IL-17A
and IL4I1
We asked then how anti-CD3-CD28 stimulation of Th17 cells
could induce NF-kBp65 phosphorylation (Figure 2B) despite
the abnormalities in the pathway of CD3 signaling. Intriguingly,
among genes in the microarray analysis, we found that CD28
was upregulated in Th17 compared to Th1 cell clones. This
finding was confirmed by both quantitative RT-PCR and flow
cytometry analysis in Th17 and Th1 cell clones (Figure S4A
and Figure 6A). A similar difference was also observed by as-
sessing CD28 expression in ex vivo PB-derived Th17 and Th1
cells (Figure S4B). The higher expression of CD28 in Th17 cells
was found to be RORC dependent, inasmuch as RORC viral
transduction increased its expression in Th1 cells (Figure 6B),
whereas RORC silencing in Th17 cells decreased CD28 expres-
sion (Figure 6C). Furthermore, ChIP experiments on Th17 cell
clones with an anti-human RORC provided direct evidence on
the linking between RORC and CD28 (Figure 6D).
Next, we investigated whether RORC-dependent CD28 hy-
perexpression could account for NF-kBp65 phosphorylation in
Th17 cells. CD28 triggering in the absence of CD3 stimulation
induced NF-kBp65 phosphorylation only in Th17 (not in Th1)
cell clones (Figure 6E). In order to understand whether CD28-
mediated NF-kB activation in Th17 cells was dependent on
PI3K activation, we evaluated the phosphorylation status of
PI3K downstream targets PDK1 and AKT (Thr308 and Ser473).
PDK1 and AKT (Thr308 and Ser473) were phosphorylated by
anti-CD3 or anti-CD3-CD28 crosslinking, but not by anti-CD28
alone, in Th1 cells. Alternatively, none of the above-mentioned
conditions was able to induce PDK1 and AKT (Thr308 and
Ser473) phosphorylation in Th17 cells (Figures 6F, S4C and
S4D).
Finally, Th1 cell clones were unable to produce IFN-g in the
absence of CD3 stimulation, whereas Th17 cell clones produced
IL-17A and CXCL8 upon CD28 triggering alone (Figures 6G and
6H and data not shown). The ability of CD28 to induce NF-kB
phosphorylation in Th17 cells could also account for the upregu-
lation of IL4I1 induced by anti-CD3-CD28 stimulation (see Fig-
ure 4A). Indeed, stimulation of Th17 cell clones by anti-CD28
in the absence of CD3 triggering was able to substantially upre-
gulate IL4I1 mRNA expression (Figure 6I).
Taken all together, these findings indicate that the high CD28
expression in Th17 cells is strictly related to RORC; moreover,
triggering of CD28, even in the absence of CD3 stimulation, is
sufficient to induce both IL-17 production and IL4I1 mRNA
upregulation.
Th17 Cells in SF of JIA Patients Express Higher IL4I1
and CD28 mRNA Expression than Th1 Cells
Similar results were also obtained by testing T cells freshly
derived from the SF of JIA patients. Indeed, IL4I1 and CD28
mRNA expression was found to be substantially higher in Th17
than in Th1 cells in these patients (Figure 7A), and activation
with anti-CD3-CD28 resulted in a substantial lower proliferation
of Th17 in comparison to Th1 cells (Figure 7B).
Figure 4. Upregulation of IL4I1 in Th17 Cells
(A) IL4I1mRNA expression by Th1 (n = 10) and Th17 (n = 10) cell clones induced by anti-CD3-CD28 stimulation, was evaluated by real-time quantitative RT-PCR.
Results were normalized to GAPDH mRNA.
(B) IL4I1mRNA expression by ex-vivo-derived PB Th1 (n = 3) and Th17 (n = 3) cells was evaluated by real-time quantitative RT-PCR. Results were normalized to
GAPDH mRNA.
(C and D) IL4I1 mRNA expression by CD3+CD4+CD161+ and CD3+CD4+CD161 freshly derived UCB cells (n = 3) (C) and newborn thymocytes (n = 3) (D) were
evaluated by real-time quantitative RT-PCR. Results were normalized to GAPDH mRNA.
(E) RORC, IL17A, and IL4I1mRNA expression by UCB CD4+CD161+ cells (n = 6) cultured in vitro for 2 weeks in the presence or in the absence of IL-1b plus IL-23
was evaluated by real-time quantitative RT-PCR. Results are expressed as mRNA concentration (fg/5,000 cells).
Results are expressed as mean values (±SE) of the indicated number of experiments.
(F) Expression of IL4I1 mRNA was evaluated by real-time quantitative RT-PCR in IL4I1 and NT (nontargeting) siRNA nucleofected Th17 cell clones (n = 3) 96 hr
after nucleofection. Results were normalized to GAPDH mRNA. Proliferation of IL4I1 and NT siRNA nucleofected Th17 cell clones (n = 3) induced by anti-CD3-
CD28 was evaluated by 3H-TdR uptake at the indicated time points. IL2mRNA expresssion in anti-CD3-CD28-stimulated IL4I1 and NT siRNA nucleofected Th17
cell clones (n = 3) was evaluated by RT-PCR at the indicated time points. Results were normalized to GAPDH mRNA.
See also Figure S2. Results are expressed as mean values of three replicates (±SE).
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Figure 5. IL4I1 Expression in Th17 Cells Is RORC
Dependent
(A) Expression of RORC, IL4I1, and IL2 mRNA was eval-
uated by real-time quantitative RT-PCR in empty vector-
and RORC2-transduced, anti-CD3-CD28-stimulated Th1
cells (n = 3). Results were normalized to GAPDH mRNA.
(B) Numbers of viable cells of empty vector- and RORC2-
transduced Th1 cells (n = 3) were evaluated at different
time points of in vitro cultures.
(C) Expression of RORC and IL4I1 mRNA was evaluated
by real-time quantitative RT-PCR in RORC and NT siRNA
nucleofected, Th17 cell clones (n = 3) 96 hr after nucleo-
fection. Results were normalized to GAPDH mRNA.
(D) Proliferation of RORC and NT siRNA nucleofected
Th17 cell clones (n = 3), induced by anti-CD3-CD28
stimulation for 4 days, was evaluated by 3H-TdR uptake.
Results are expressed as fold change of RORC versus NT
siRNA nucleofected Th17 cell clones.
(E) ChIP was performed with anti-human RORC on a pool
of Th17 cell clones stimulated with anti-CD3-CD28.
The immunoprecipitated DNA was amplified in real-time
RT-PCR with primers specific for IL4I1 and GAPDH
promoters, and the results obtained with theDDCtmethod
were then plotted as percentage of total input. Three
independent experiments have been performed.
See also Figure S3. Results are expressed as mean values
(±SE) of the indicated number of experiments.
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characteristics of Th17 cell clones and circulating Th17 cells
from healthy subjects, i.e., high IL4I1 and CD28 mRNA expres-
sion and impaired proliferation in response to anti-CD3-CD28
stimulation.
DISCUSSION
In this study, we wanted to test the hypothesis that the low
number of Th17 cells found in the inflamed tissue of subjects
affected by Th17 cell-mediated disorders could be due to the
inability of these cells to proliferate and to expand in response
to antigen stimulation.
First, we showed that in response to anti-CD3-CD28 stim-
ulation, Th1 cells exhibited a strong proliferation and IL-2208 Immunity 36, 201–214, February 24, 2012 ª2012 Elsevier Inc.production, whereas Th17 cells did not. Further-
more, Th17 cell clones also exhibited a reduced
ability to respond to IL-2 in comparison with
Th1 cell clones; in fact, IL-2 addition in culture
of anti-CD3-CD28-stimulated Th17 cell clones
only partially restored their proliferation. These
abnormalities were also shared by ex-vivo-
derived circulating Th17 cells, suggesting that
we were not facing an artifact resulting from
the use of long-term cultured Th17 cells.
The reduced ability of Th17 cell clones to
respond to IL-2 was not due to a lower ex-
pression of IL2RA, IL2RB, and IL2RG mRNA
than Th1 cell clones but, rather, was related to
an impaired signal transduction via the IL-2R.
Indeed, stimulation of Th17 cells with IL-2
resulted in a significant impairment of PI3K-AKT-mTORC1 axis activation, as revealed by the reduced
S6ribo phosphorylation. Taken together, these data provide
clear evidence that Th17, unlike Th1, cells exhibit poor or no
proliferation because of at least two reasons: (1) an impairment
to produce IL-2 in response to anti-CD3-CD28 stimulation and
(2) a reduced ability to respond to IL-2.
It has to be noted that a similar behavior, i.e., reduced IL-2
response, is shown by CD4+CD25+Foxp3+ T regulatory (Treg)
cells. Indeed, IL-2R signaling distinctively regulates Treg and
T effector (Teff) cells, inducing activation of PI3K-AKT and
STAT5 in Teff cells and of STAT5 only in Treg cells (Cheng
et al., 2011). However, these findings were not investigated
further and they remain presently unclear.
In this study, we focused on the mechanisms accounting for
impaired IL-2 expression and production in Th17 cells. The
Immunity
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to IL2 promoter activation revealed that Th17 cells stimulated
with anti-CD3-CD28 had a substantially lower mRNA expression
of several binding factors for the promoter of IL2 gene (JUN,
FOS, and NFATC1) compared to Th1 cells. In addition, whereas
anti-CD3-CD28 stimulation induced NF-kBp65 phosphorylation
in either Th17 or Th1 cells, phosphorylation of both c-Fos and
c-Jun, as well as NF-ATc2 nuclear localization and NF-AT
binding to TRE of IL2 gene promoter, were substantially lower
in Th17 than in Th1 cells.
Thus, it appears that, among all transcription factors involved
in IL2 gene promoter activation, only NF-kBp65 is activated by
anti-CD3-CD28 stimulation in Th17 cells.
Going back to the chain of events occurring between TCR
triggering and the IL2 gene promoter activation, it is noteworthy
that Th17 cells showed substantial reduced CD3z and CD3ε
chain expression in comparison with Th1 cells. Accordingly,
CD3z, as well as ZAP-70 and SLP-76, showed a substantial
lower phosphorylation in Th17 than in Th1 cells, in response to
anti-CD3-CD28 stimulation. To better understand these findings,
we took advantage of microarray data looking at the expression
of genes possibly involved in the control of the initial phases
after CD3 signaling in both Th1 and Th17 cells. One possible
candidate gene, IL4I1, was substantially upregulated in Th17
cells. IL4I1, which was first described in B cells (Chu and Paul,
1997), was then detected even onDCs in bothmice and humans,
where it encodes a secreted L-phenylalanine oxidase, which
associates with a temporary decrease in CD3z chain and inhibi-
tion of T lymphocyte proliferation, as a consequence of the
enzymatic production of H2O2 (Boulland et al., 2007). The data
reported in this study show that IL4I1 mRNA was highly ex-
pressed in unstimulated Th17 cells and is further upregulated
after their activation, whereas its expression was virtually unde-
tectable in either resting or stimulated Th1 cells. The IL4I1
expression in Th17 cells can explain why these cells show
reduced CD3z and CD3ε chain expression and accounts for
their impairment in CD3z, ZAP70, SLP76, c-Jun, and c-Fos
phosphorylation and, at least in part, impaired NF-AT activation
and its nuclear translocation after anti-CD3-CD28 stimulation.
Accordingly, silencing of IL4I1 in human Th17 cells substantially
increased their proliferation and their ability to produce IL-2.
This study also demonstrates that IL4I1 mRNA expression in
human Th17 cells is strictly RORC dependent. Indeed, RORC
transduction in Th1 cells not only induced high IL17A, IL17F,
and IL4I1 expression, but it also made these cells unable to
proliferate and to produce IL-2 in response to anti-CD3-CD28
stimulation. Furthermore, RORC silencing in Th17 cells markedly
decreased IL4I1 mRNA expression, further supporting the
concept of a direct relationship between the presence of
RORC and the inability of Th17 cells to produce IL-2 and to prolif-
erate. Finally and most importantly, ChIP experiments on Th17
cell clones by the use of a RORC Ab clearly demonstrated the
direct binding of RORC to putative IL4I1 regulatory elements.
IL4I1 mRNA was already detectable in RORC+CD4+CD161+
UCB and thymic Th17 cell precursors, supporting the concept
that RORC, CD161, and IL4I1 expression represents a common
feature of the human Th17 cell lineage. It is also of note that IL4I1
mRNA expression was strongly increased, together with those
of RORC, RORA, IL17A, and IL17F, when CD4+CD161+ humanTh17 cell precursors were cultured in vitro in the presence of
IL-1b and IL-23, a condition that allows human Th17 cell polari-
zation (Cosmi et al., 2008).
The inability of Th17 cells to respond to TCR stimulation, which
is due to the RORC-dependent IL4I1 mRNA upregulation, is
apparently in contrast with the observation that these cells
upregulate IL17A and IL4I1 expression upon anti-CD3-CD28
activation. However, both data in the literature and the findings
reported in this study may provide an explanation for this
apparent discrepancy. Although many aspects of the molecular
pathway involved in the IL-17A production are still unknown, it
has been shown that the activation of NF-kB family members
RelA and RelB is essential for the regulation of IL-17A expression
in mice gd T cells (Powolny-Budnicka et al., 2011) and that IKKa
selectively associates with IL17A locus, inducing its transcrip-
tional activation (Li et al., 2011). In addition, it has been shown
that IL4I1 mRNA expression is regulated by NF-kB pathway
(Julia` et al., 2007; Marquet et al., 2010). These findings are in
keeping with the observation reported in the present study
showing that NFKB1 and RELA mRNA expression and NF-
kBp65 phosphorylation were not altered in Th17 cells when
compared to Th1 cells. In addition it is known that, in the absence
of TCR triggering, CD28 signaling can selectively regulate the
expression of cytokines-chemokines and prosurvival proteins
via the activation of an alternative—like IKKa-dependent NF-
kB pathway (Marinari et al., 2004; Tuosto, 2011).
In this study, we found that CD28 expression is strongly upre-
gulated in Th17 cells, as shown by the microarray analysis and
confirmed by quantitative PCR. Similar findings have recently
been reported by Turtle et al. (2011), who found high CD28
expression in a subset of TCRab+CD8a+CD161+ memory adult
cells showing also high expression of type 17-associated genes
and downregulation of TCR signaling. However, themechanisms
responsible for downregulation of TCR signaling, as well as
the role of RORC in such downregulation and in CD28 hyperex-
pression, were not investigated. Of note, indeed, in our study
the higher CD28 expression in Th17 cells than in Th1 cells, like
the upregulation of IL4I1 responsible for downregulation of
TCR signaling, was RORC dependent, inasmuch as RORC2 viral
transduction increased its expression in Th1 cells, whereas
RORC silencing decreased its expression in Th17 cells. More-
over, ChIP experiments on Th17 cell clones by the use of a
RORC Ab clearly demonstrated the existence of a direct link of
RORC with IL4I1 and CD28 promoter. We also found that
CD28 stimulation in the absence of CD3 triggering was able to
induce NF-kBp65 phosphorylation, IL-17A production, and
IL4I1 upregulation in Th17 cells, whereas it had no effect on
NF-kBp65 phosphorylation and IFN-g production in Th1 cells.
The NF-kB phosphorylation induced by CD28 triggering alone
could be due to a PI3K-dependent or -independent mechanism
(Tuosto, 2011). Data reported here demonstrate that both PI3K
downstream targets PDK1 and AKT were phosphorylated by
triggering of CD3 or CD3 plus CD28, but not by triggering
CD28 alone, in Th1 cells and in none of these conditions in
Th17 cells. These data suggest that CD28-mediated NF-kBp65
phosphorylation in Th17 cells acted via a PI3K-independent
pathway. It is of note that the lack of PI3K-AKT pathway activa-
tion in Th17 cells may further explain the recent data, showing
that Th17 cells have impaired IL-2 production and proliferationImmunity 36, 201–214, February 24, 2012 ª2012 Elsevier Inc. 209
Figure 6. CD28 Is RORC-Dependently Upregulated in Th17 Cells and Its Stimulation Is Sufficient to Induce Both NF-kB Activation and IL-17A
Production Independently of PI3K Activation
(A) CD28 protein expression by resting Th1 (n = 5) and Th17 (n = 5) cell clones was evaluated by flow cytometry. Results are expressed as difference between
CD28 MFI and its appropriate isotype control MFI. One representative histogram is also shown. Dotted lines represent the staining of isotype controls.
(B) Expression of CD28 mRNA was evaluated by real-time quantitative RT-PCR in empty vector-transduced and RORC2-transduced Th1 cells (n = 3). Results
were normalized to GAPDH mRNA.
(C) Expression of CD28 mRNA was evaluated by real-time quantitative RT-PCR in RORC and NT siRNA nucleofected Th17 cell clones (n = 3) 96 hr after
nucleofection. Results were normalized to GAPDH mRNA.
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trascription factor 1, which is a well-known target of AKT activity
(Oh et al., 2011). At present, we may speculate that human
Th17 cells differ from other subsets of CD4+ T cell effectors
because, upon stimulation, they possess a RORC-dependent
block of IL-2 production and their subsequent proliferation but
maintain the ability to produce IL-17A.
Th17 cells have strong protective and proinflammatory
properties, resulting from their ability to produce cytokines
acting on several immune and nonimmune cell types. The
RORC-dependent impairment of cell proliferation, based on
the block of the chain of events leading from TCR stimulation
to the production of the autocrine T cell growth factor, IL-2
may therefore represent an important mechanism of self-regula-
tion of human Th17 cell expansion at level of inflamed tissues.
This has been confirmed, although indirectly, by the observation
that Th17 cells present in the SF of JIA patients (Cosmi et al.,
2011) also exhibited the same abnormalities in IL-2 production
and in the ability to proliferate as Th17 cell clones and ex-vivo-
derived circulating Th17 cells from healthy subjects. The hypoth-
esis that the impairment in Th17 cell expansion reflects a
mechanism for attenuating their potentially high dangerousness
is also consistent with the observation that, once activated,
Th17 cells tend to shift to the Th1 cell phenotype in both humans
and mice.
In this study we provide an explanation of why Th17 cells,
despite their well-known pathogenic role in some inflammatory
disorders, are very rare in the inflammatory sites. This phenom-
enon is due, at least in part, to the inability of this cell subset to
expand because they have abnormalities in the molecular
pathway that allows IL-2 production and, consequently, cell
proliferation in response to TCR stimulation. These abnormalities
are related to the upregulation of IL4I1 mRNA, which is strictly
dependent on the activity of the Th17 cell master gene RORC.
RORC is also responsible for the upregulation in Th17 cells of
CD28, whose stimulation allows IL-17A production even in
absence of TCR triggering. Thus, the rarity of human Th17 cells
in inflamed tissues is the result of RORC-dependent mecha-
nisms that limit their expansion and, therefore, reduce their
potential dangerousness.EXPERIMENTAL PROCEDURES
Cell Sources
PB samples were obtained from eight adult healthy volunteers. UCB samples
were obtained from nine donors. Normal postnatal thymus mononuclear cells
were obtained from three children who underwent corrective cardiac surgery.(D) ChIP was performed with anti-human RORC on a pool of Th17 cell clones st
real-time RT-PCR with primers specific for CD28 and GAPDHP promoters, and t
input. Three independent experiments have been performed.
(E and F) Phosphorylation of NF-kBp65 (E) and PDK1 (F) in Th1 (n = 4) and Th17 (n
was evaluated by flow cytometry. Results are expressed as fold change of MFI i
(G) Intracellular IFN-g and IL-17 production by Th1 (n = 3) and Th17 (n = 3) cel
evaluated by flow cytometry. One representative experiment is shown.
(H) IFN-g and IL-17 production by Th1 (n = 3) and Th17 (n = 3) cell clones indu
supernatants by the CBA assay. Results are expressed as cytokine concentratio
(I) IL4I1mRNA expression by Th1 (n = 3) and Th17 (n = 3) cell clones induced by a
quantitative RT-PCR. Results were normalized to GAPDH mRNA.
See also Figure S4. Results are expressed as mean values (±SE) of the indicatedSF samples were obtained from six JIA patients defined according to the ILAR
classification. The procedures followed in the study were in accordance with
the ethical standards of the Regional Committee on Human Experimentation.
T Cell Recovery and Expansion
Mononuclear cell (MNC) suspensions were obtained from PB, UCB, and
thymuses by centrifugation on Ficoll-Hypaque gradient. CD4+ single-positive
thymocytes and CD4+ T cells from PB or UCB were negatively selected by
high-gradient magnetic cell sorting (Miltenyi Biotec, Bergisch Gladbach), as
described elsewhere (Santarlasci et al., 2009). CD4+ T cells from the different
tissues were then further divided into CD161+ and CD161 by immunomag-
netic cell sorting (Miltenyi Biotec). In an additional experiment, PB
CD4+CD161+ and CD4+CD161 T cell population were further subdivided in
CCR6+ and CCR6 cell fraction by FACSAria (BD Biosciences) and then
cultured under limiting dilution in order to obtain Th17 and Th1 cell clones,
respectively (Cosmi et al., 2010). Purified UCB CD4+CD161+ T cells were
stimulated for 7 days with anti-CD3-CD28 (5 mg/ml each), in the absence or
presence of IL-1b (10 ng/ml) plus IL-23 (20 ng/ml). On day 7, T cells were
restimulated under their primary culture condition. On day 14, T cells were
collected and analyzed.
Intracellular Cytokine Production Assay
T cells were analyzed for intracellular IL-17A and IFN-g production upon 6 hr
PMA-ionomycin stimulation, the last 4 hr of which were in the presence of
brefeldin A. In some experiments, T cell clones were stimulated with anti-
CD3 (5 mg/ml), anti-CD28 (5 mg/ml), or anti-CD3-CD28, followed by cross-
linking of the primary antibodies with an anti-isotype, for 6 hr, the last 4 hr of
which were in the presence of brefeldin A. The cells were then fixed in formal-
dehyde and analyzed on a BDLSR II flow cytometry (BD Biosciences).
T Cell Proliferation
13 105 T cells from Th17 and Th1 cell clones or CD3+CD4+ CD161+IL-17+IFN-
g and CD161IL-17IFN-g+ cells were cultured for 3 days with anti-CD3-
CD28 (5 mg/ml each), in the presence or absence of IL-2 (50 IU/ml) or with
PMA-ionomycin. On day 3, the T cell culture supernatants were recovered in
order to evaluate cytokine production, whereas cells were pulsed for 8 hr
with 0.5 mCi of 3H-TdR (Perkin Elmer) and harvested, and radionuclide uptake
was measured by scintillation counting.
Cytokine Secretion Assay and Cell Culture
CD4+CD161+ and CD4+CD161 cells from PB of six healthy donors and SF of
six JIA patients were stimulated with PMA-ionomycin, recovered after 3.5 hr,
washed, and then stained with IFN-g and IL-17 catch reagents (Miltenyi
Biotec), according to manufacturer instructions. After an additional 45 min of
incubation (37C, 5% CO2), cells were stained with anti-CD3-Pacific Blue,
-CD161-PE, -IL-17-APC, and -IFN-g-FITC, analyzed, and sorted by FACSAria
into CD3+CD161+IL-17+IFN-g and CD3+CD161IL-17IFN-g+ cells.
RNA Isolation, cDNA Synthesis, and Real-Time Quantitative RT-PCR
Total RNA was extracted by with the RNeasy Micro kit (QIAGEN) and treated
with DNase I to eliminate possible genomic DNA contamination. Taq-Man
RT-PCR was performed, as described elsewhere (Santarlasci et al., 2009).
Primers and probes used were purchased from Applied Biosystems.imulated with anti-CD3-CD28. The immunoprecipitated DNA was amplified in
he results obtained with the DDCt method were plotted as percentage of total
= 4) cell clones induced by anti-CD3, anti-CD28, or anti-CD3-CD28 stimulation
n stimulated versus unstimulated (time 0) cultures.
l clones induced by anti-CD3, anti-CD28, or anti-CD3-CD28 stimulation was
ced by anti-CD3, anti-CD28, or anti-CD3-CD28 stimulation was evaluated in
n (pg/ml).
nti-CD3, anti-CD28, or anti-CD3-CD28 stimulation was evaluated by real-time
number of experiments.
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Figure 7. Th17 Cells Present in Synovial
Fluid of Juvenile Idiopathic Arthritis-
Affected Children Express Higher IL4I1 and
CD28 mRNA Expression than Th1 Cells
(A) Expression of RORC, IL4I1, and CD28
mRNA was evaluated by real-time quantitative
RT-PCR in CD4+CD161IL-17IFN-g+ (Th1) and
CD4+CD161+IL-17+IFN-g (Th17) cells derived
from the SF of JIA children (n = 6). Results were
normalized to GAPDH mRNA.
(B) Proliferation of CD4+CD161IL-17IFN-g+
(Th1) and CD4+CD161+IL-17+IFN-g (Th17) cells
derived from the SF of JIA children (n = 4) induced
by anti-CD3-CD28 was evaluated by 3H-TdR
uptake.
Results are expressed asmean values (±SE) of the
indicated number of experiments.
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GAPDH expression.
Cytokine Quantification
IL-2, IL-17A, and IFN-g protein concentration in cell culture supernatants
was assessed by Cytometric Bead Array (CBA) human cytokine kit (BD
Biosciences) according to manufacturer instructions.
Phospho-Protein Assays
Phospho-c-Jun (S63), ZAP-70 (Y319), and SLP76 (Y145) were evaluated by
BD Cytometric Bead Array (CBA) Cell Signaling Flex Set (BD Biosciences)
according to manufacturer instructions. Phospho-PDK1 (Abcam), STAT5,
NF-kBp65, CD32 (BD Biosciences), and c-Fos, AKT, S6ribo (Cell Signaling,
Danvers, MA) were evaluated by PhosFlow (BD Biosciences) intracellular
cell staining according to manufacturer instructions. Detailed report of the
procedure is available in Supplemental Information.
RORC2 Lentivirus Transduction
Th1 cell clones (n = 3) were activated with irradiated (9,000 rads) APCs (1:2)
plus anti-CD3 (1 mg/ml) and IL-2 (50 U/mL, Eurocetus, Italy). After 16 hr,
pCCL EF1a NGFR or pCCL EF1a NGFR hRORC2 lentivirus (Crome et al.,
2009) were added at a multiplicity of infection (MOI) of 10 and cells were
spinoculated at 1,200 3 g, 26C for 2 hr. Transduced T cells were kept
in culture with IL-2 (100 U/ml), purified after 10 days with anti-NGFR-PE212 Immunity 36, 201–214, February 24, 2012 ª2012 Elsevier Inc.(BD Biosciences) plus anti-PE microBeads (Milte-
nyi Biotec); purities greater than 98% being
consistently achieved, and then expanded with
irradiated APCs, anti-CD3 plus IL-2 for other
2 weeks. The proliferation of transduced T cell
clones was evaluated by cell counting, excluding
the death cells by evaluating the Trypan blue-
positive cells.
siRNA Delivery and Gene Silencing
107 cells of Th17 cell clones (n = 3) were tran-
siently nucleofected with 3 mM of hIL4I1-siRNA
(ON-TARGET plus SMART pool, Thermo Fisher
Scientific, Lafayette, CO) or hRORC-siRNA
(siGENOME SMARTpool, Thermo Fisher Scien-
tific), by electroporation with the Amaxa Nucleo-
fector (program T-020; Amaxa Biosystems) with
the Human T Cell Nucleofector Kit (Lonza Basel,
Switzerland). Nontargeting ON-TARGET plus or
siGENOME, siRNA Pool (Thermo Fisher Scien-
tific), were used as negative control of hIL4I1-or
hRORC-siRNA, respectively. Cells were har-
vested at 72, 96, and 120 hr for mRNA evaluationby RT-PCR, and cell proliferation induced by anti-CD3-CD28 stimulation was
evaluated after an additional 72 hr.
NF-AT Activity Evaluation
Th1 (n = 8) and Th17 (n = 10) cell clones were activated with irradiated
(9,000 rads) APCs (1:2) plus anti-CD3 (1 mg/ml) and IL-2 (50 U/mL, Eurocetus,
Italy). After 16 hr, cells were transduced with lentivirus particles, expressing
an inducible NF-AT-responsive reporter gene (firefly luciferase) under the
control of NF-AT’s specific Transcriptional Response Element (TRE), Cignal
Lenti NF-AT Reporter (luc) (SABiosciences, Frederick, MD). Cells were trans-
duced at an MOI of 50 in the presence of polybreen (8 mg/ml) (Sigma-Aldrich,
St. Louis, MO, USA), spinoculated at 1,2003 g, 26C for 2 hr, and then kept in
culture with IL-2 (50 U/ml). Before NF-AT activity evaluation, cells were starved
overnight in medium alone; the day after, cells were stimulated (or not) with
anti-CD3-CD28 for 3, 6, 12, and 24 hr; luciferase activity was then evaluated
with Luciferase Assay System (Promega Corporation, Madison, WI, USA).
Normalization was performed on cell number evaluated by flow cytometry
with Trucount Tubes (BD Biosciences).
Chromatin Immunoprecipitation
ChIP was performed essentially as described (Nebbioso et al., 2005) with anti-
human RORC, clone ab41941 (Abcam; Cambridge, UK) on Th17 cell clones
stimulated with anti-CD3-CD28 for 6 hr. The quantitative PCR, performed in
an abi 7500 thermal Cycler, was carried out with different sets of primer after
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Self-Regulation of Th17 Cell Expansionanalyzing in silico published sequences of CD28 and IL4I1 looking for putative
promoter regions with TRED Database (Jiang et al., 2007) and published
sequences (Wiemann et al., 2005). Primers used will be available on request.
After amplification, data were analyzed according a standard calculation
(DDCt method) and controlled against a no-Ab input. Finally, RORC-immuno-
precipitated DNA values obtained in quantitative PCR for CD28 and IL4I1
promoters were plotted as percentage of total chromatin input.
Microarray
Gene expression profiles on human Th1 and Th17 cell clones were assessed
by cDNA microarray technique with One Color Microarray Quick Labeling kit
(Agilent Technologies, Cernusco s/N, MI, Italy), as detailed in Supplemental
Information.
Statistics
A standard two-tailed paired or unpaired t test was used for statistical analysis;
p values of 0.05 or less were considered significant.ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE30664.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.immuni.2011.12.013.
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